The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
Clowes, A. W., Reidy, M. A., & Clowes, M. M. (1983) · PubMed · Cited by 1,437
Inhibition of Neointimal Smooth Muscle Accumulation After Angioplasty by an Antibody to PDGF
Ferns, G. A. A., Raines, E. W., Sprugel, K. H., Motani, A. S., Reidy, M. A., & Ross, R. (1991) · Science · doi:10.1126/science.1653454 · Cited by 1,065
Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular Injury
Powell, J. S., Clozel, J.-P., Müller, R. K. M., Kuhn, H., Hefti, F., Hosang, M., & Baumgartner, H. R. (1989) · Science · doi:10.1126/science.2526370 · Cited by 1,052
Lindner, V, & Reidy, M. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3739 · Cited by 719
Jawien, A., Bowen-Pope, D. F., Lindner, V, Schwartz, S. M., & Clowes, A. W. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115613 · Cited by 674
Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.
Agrawal, S., Temsamani, J., & Tang, J. Y. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7595 · Cited by 561
Role of basic fibroblast growth factor in vascular lesion formation.
Lindner, V, Lappi, D. A., Baird, A., Majack, R. A., & Reidy, M. A. (1991) · Circulation Research · doi:10.1161/01.res.68.1.106 · Cited by 517
New light on Myc and Myb. Part II. Myb.
Luscher, B., & Eisenman, R. N. (1990) · Genes & Development · doi:10.1101/gad.4.12b.2235 · Cited by 478
Cited by
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Signal transduction and regulation in smooth muscle
Somlyo, A. P., & Somlyo, A. V. (1994) · Nature · doi:10.1038/372231a0 · Cited by 1,902
The Basic Science of Gene Therapy
Mulligan, R. C. (1993) · Science · doi:10.1126/science.8493530 · Cited by 1,741
Brem, H., Piantadosi, S., Burger, P. C., Walker, M., Selker, R., Vick, N. A., Black, K., Sisti, M., Brem, S., Mohr, G., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90755-6 · Cited by 1,389
Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?
Stein, C. A., & Cheng, Y.-C. (1993) · Science · doi:10.1126/science.8351515 · Cited by 1,303
New Challenges in Biomaterials
Peppas, N. A., & Langer, R. (1994) · Science · doi:10.1126/science.8134835 · Cited by 1,142
Self-citationThe Intima: Soil for Atherosclerosis and Restenosis
Schwartz, S. M., deBlois, D., & O’Brien, E. R. M. (1995) · Circulation Research · doi:10.1161/01.res.77.3.445 · Cited by 971
Current status of polymeric gene delivery systems☆
PARK, T., JEONG, J., & KIM, S. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.03.007 · Cited by 944
von der Leyen, H. E., Gibbons, G. H., Morishita, R., Lewis, N. P., Zhang, L., Nakajima, M., Kaneda, Y., Cooke, J. P., & Dzau, V. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1137 · Cited by 762
Gene inhibition using antisense oligodeoxynucleotides
Wagner, R. W. (1994) · Nature · doi:10.1038/372333a0 · Cited by 736
Topol, E. J., Leya, F., Pinkerton, C. A., Whitlow, P. L., Hofling, B., Simonton, C. A., Masden, R. R., Serruys, P. W., Leon, M. B., Williams, D. O., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307223290401 · Cited by 698
Lee, K. S., Buck, M., Houglum, K., & Chojkier, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118304 · Cited by 539
Scott, N. A., Cipolla, G. D., Ross, C. E., Dunn, B., Martin, F. H., Simonet, L., & Wilcox, J. N. (1996) · Circulation · doi:10.1161/01.cir.93.12.2178 · Cited by 501
Gallo, R., Padurean, A., Jayaraman, T., Marx, S., Roque, M., Adelman, S., Chesebro, J., Fallon, J., Fuster, V., Marks, A., et al. (1999) · Circulation · doi:10.1161/01.cir.99.16.2164 · Cited by 490
Morishita, R., Gibbons, G. H., Ellison, K. E., Nakajima, M., Zhang, L., Kaneda, Y., Ogihara, T., & Dzau, V. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8474 · Cited by 458
Chang, M. W., Barr, E., Seltzer, J., Jiang, Y.-Q., Nabel, G. J., Nabel, E. G., Parmacek, M. S., & Leiden, J. M. (1995) · Science · doi:10.1126/science.7824950 · Cited by 446
Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial Injury
Ohno, T., Gordon, D., San, H., Pompili, V. J., Imperiale, M. J., Nabel, G. J., & Nabel, E. G. (1994) · Science · doi:10.1126/science.8047883 · Cited by 433
Progress in antisense technology
Crooke, S. T. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104408 · Cited by 417
Coronary in-stent restenosis: Current status and future strategies
Lowe, H. C., Oesterle, S. N., & Khachigian, L. M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01742-9 · Cited by 414
Pathobiology of intimal hyperplasia
Davies, M. G., & Hagen, P.-O. (1994) · Journal of British Surgery · doi:10.1002/bjs.1800810904 · Cited by 413
Ylä-Herttuala, S., & Martin, J. F. (2000) · The Lancet · doi:10.1016/s0140-6736(99)04180-x · Cited by 375
Mouse model of arterial injury.
Lindner, V, Fingerle, J., & Reidy, M. A. (1993) · Circulation Research · doi:10.1161/01.res.73.5.792 · Cited by 363
Chang, M. W., Barr, E., Lu, M. M., Barton, K., & Leiden, J. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118281 · Cited by 354
Noiri, E., Peresleni, T., Miller, F., & Goligorsky, M. S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118681 · Cited by 343
Guvakova, M. A., Yakubov, L. A., Vlodavsky, I., Tonkinson, J. L., & Stein, C. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2620 · Cited by 326
Burgess, T. L., Fisher, E. F., Ross, S. L., Bready, J. V., Qian, Y. X., Bayewitch, L. A., Cohen, A. M., Herrera, C. J., Hu, S. S., & Kramer, T. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.4051 · Cited by 320
Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.
Beltinger, C., Saragovi, H. U., Smith, R. M., LeSauteur, L., Shah, N., DeDionisio, L., Christensen, L., Raible, A., Jarett, L., & Gewirtz, A. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117860 · Cited by 312
Cell Cycle Progression: New Therapeutic Target for Vascular Proliferative Disease
Braun-Dullaeus, R. C., Mann, M. J., & Dzau, V. J. (1998) · Circulation · doi:10.1161/01.cir.98.1.82 · Cited by 285
Lincoff, A. M., Furst, J. G., Ellis, S. G., Tuch, R. J., & Topol, E. J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00584-0 · Cited by 282
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.023 · Cited by 270
Antisense oligonucleotides: towards clinical trials
Agrawal, S. (1996) · Trends in Biotechnology · doi:10.1016/0167-7799(96)10053-6 · Cited by 265
Stein, C. A. (1995) · Nature Medicine · doi:10.1038/nm1195-1119 · Cited by 255
Hasty, A. H., Linton, M. F., Brandt, S. J., Babaev, V. R., Gleaves, L. A., & Fazio, S. (1999) · Circulation · doi:10.1161/01.cir.99.19.2571 · Cited by 105
Metadata
- Authors
- Simons, M., Edelman, E. R., DeKeyser, J.-L., Langer, R., & Rosenberg, R. D.
- Venue
- Nature
- Published
- 1992-09
- Volume
- 359
- Issue
- 6390
- Pages
- 67-70
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2034487226
- Cited by
- 731
- References
- 22
- FWCI
- 28.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.